VRT:NYSE

Vertiv Holdings, LLC

Data as of 2026-03-10 - not real-time

$264.35

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Vertiv Holdings (VRT) is trading well above its 20‑day, 50‑day and 200‑day moving averages at $264.35, indicating a strong bullish trend, but the RSI of 66 hints at near‑term overbought conditions. Technical momentum is mixed: the MACD histogram is negative and the signal line is bearish, while price sits just below the 52‑week high of $266.67 and the identified resistance level of $266.65. Valuation metrics are stretched – the forward PE of 33.5 and trailing PE of 70.9 dwarf the industry average PE of 29.5, and the DCF‑derived fair value of $126.6 suggests a ~44% downside from current levels. The stock exhibits very high volatility (≈84% 30‑day) and a beta of 2.1, underscoring heightened market sensitivity. On the fundamentals side, revenue grew 22.7% YoY, margins remain solid (gross 36%, operating 21%), and ROE is an impressive 41.8%, but leverage is elevated with a debt‑to‑equity of 81.9% and net debt exceeding $1.3 B. Recent news adds momentum: a quarterly dividend was declared, earnings beat expectations, the company was added to the S&P 500, and demand for data‑center infrastructure continues to surge, all supporting a bullish outlook despite the lofty price.

Trading Recommendations

Short Term

< 1 year
hold
Conviction: 6/10

Key Factors

  • Price near technical resistance and overbought RSI
  • Bearish MACD histogram signaling possible pullback
  • Elevated valuation relative to DCF fair value

Medium Term

1–3 years
buy
Conviction: 8/10

Key Factors

  • Strong earnings beat and accelerating revenue growth
  • Inclusion in the S&P 500 boosting institutional demand
  • Robust operating margins and high ROE supporting earnings expansion

Long Term

> 3 years
hold
Conviction: 7/10

Key Factors

  • Sustainable low‑payout dividend backed by cash generation
  • Long‑term data‑center and AI infrastructure tailwinds
  • Valuation premium remains a risk despite solid fundamentals

Key Metrics & Analysis

Financial Health

Revenue Growth22.70%
Profit Margin13.03%
P/E Ratio70.9
ROE41.81%
ROA11.12%
Debt/Equity81.90
P/B Ratio25.7
Op. Cash Flow$2.1B
Free Cash Flow$1.4B
Industry P/E29.5

Technical Analysis

TrendBullish
RSI66.5
Support$195.84
Resistance$266.65
MA 20$243.95
MA 50$203.81
MA 200$160.45
MACDBearish
VolumeStable
Fear & Greed Index75.89

Valuation

Fair Value$126.64
Target Price$263.20
Upside/Downside-0.44%
GradeOvervalued
TypeGrowth
Dividend Yield0.10%

Risk Assessment

Beta2.11
Volatility83.68%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.